LAB
NASDAQ
$0.88
Standard BioTools Inc (LAB)
Standard Biotools Inc. (LAB) is a pioneering biotechnology company dedicated to enhancing genomic analysis and biological research through cutting-edge tools and technologies. The firm's focus on developing high-performance products for laboratories in genomics and proteomics is aimed at improving research precision and operational efficiency. Utilizing proprietary platforms, Standard Biotools accelerates scientific discoveries, reinforcing its position as a leader in the dynamic biotechnology landscape. With a commitment to meeting the growing demand for innovative analytical solutions, LAB is strategically positioned to facilitate significant advancements within the life sciences sector.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $1.55 (+75.32%)
Market Cap
$328M
P/B Ratio
0.59
Profit Margin
90.7%
P/E Ratio
4.26
Price Chart
Valuation
Market Cap$328M
P/E4.26
P/S3.97
P/B0.59
Profitability
Total Revenue (TTM)$86M
Gross Profit (TTM)$46M
EBITDA-$90M
Profit Margin90.7%
Operating Margin-59.1%
EPS$0.20
Financial Health
Free Cash Flow Yield-28.77%
Growth & Risk
Revenue 5Y CAGR-9.66%
FCF 5Y CAGR+17.25%
Beta (5Y)1.56
Sharpe Ratio-0.27